[chart]investorshub.advfn.com/uimage/uploads/2017/6/28/lmzwbrabits.jpg[/chart]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
VIBI. Thanks, I have been lurking for a week or so.
VIBI. Yes Sir that is the case. :)
VIBI's 1st Quarter started on 4/01/2019. How could it be due today?
https://www.otcmarkets.com/stock/VIBI/profile
FINANCIAL REPORTING
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
12/31/2018
CIK
0001576724
Fiscal Year End
3/31
https://www.otcmarkets.com/stock/VIBI/profile
Q-4 is included in the 10-K so they get 90 days. June 30 is a Sunday so it falls on the next Day. July 1st Monday.
Non-Accelerated Filers:
10-Q: for Quarterly Period Ended 03/31/19 due Wednesday, May 15, 2019
10-K: for Fiscal Year Ended 02/28/19 due Wednesday, May 29, 2019
10-Q: for Quarterly Period Ended 04/30/19 due Friday, June 14, 2019
10-K: for Fiscal Year Ended 03/31/19 due Monday, July 01, 2019
https://www.securexfilings.com/sec-deadlines/
BYSD It's alive Today :)
Bayside Corporation. Common Stock (PN)
OTC BBN : BYSDOption Chain
$0.70 0.67 (2,700.00%)
Caverstem
Published on May 10, 2019
Dr. Victor Liu
California Regenerative Clinic
Talks about CaverStem® and providing the procedure to patients
in the San Francisco area
ALKM Is it in Africa or the US?
ALKM I would be happy with .002 to its last year high of .0028. I would save 10 mil shares if it broke out of last years high. I am not greedy. :)
ALKM......Need to tickle the froggs butt to ge it to hop. :)
CELZ Why is yesterdays 8-k not on the Ihub news feed?
GRDO..but Charlie got lucky in the pumpkin patch and now Lucy has twins. :)
ALKM 7"s Fat 8's thin could easly be Green. :)
$0.0008 0.00 (0.00%)
Bid/Ask
0.0007 / 0.0008
B/A Size
71,899,400 X 2,802,000
Volume
33,665,566
GRDO..What is wrong with 13's? I would take a few. :)
I saw it on FB Alkame shareholders under comments
ALKM...Craig Kaufman -
First,you are mistaken or misinformed. You say we are being paid. Robert nor I are taking salary. We have not taken for years. We have been accruing our salaries for several years now. We have however taken minimal and I mean minimal expense dollars.
Second, Robert is aware of your concerns and that of other investors too. As a shareholder myself I am just as frustrated as everyone else. I’m not the enemy and yes I will always defend against untruths and lies about my character. As an investor who is deemed an insider I am not allowed to discuss or divulge certain things about the company that I am may know that has not been or until made public knowledge . Btw..It’s ridiculous that some think the company is sitting on the financials .. how idiotic. Yes..It is also ridiculous on how long getting current is taking and I am just as pissed and I know you and everyone would like an explanation and I certainly can’t say anything on several fronts .. at least just not yet... shortly .I know a corp update will be coming out too. What I can say for now is believe it or not it’s not Eakle’s fault. That doesn’t help frustration levels but it is true. However, as the CEO he has no choice but as management to fall on the sword and take the blame and I give him shit on a regular basis for the delay because who else can I vent and yell at with my frustration. Trust me all will be revealed and yes shortly !
Third, you want to do my job. please you or anyone else is more than welcome to take it over if you don’t think I am doing it. You can do the job for no money too and at great personal sacrifice , twelve to fourteen hour minimum days including weekends and oh don’t forget the personal attack’s . You and your family will love Gervais. Oregon . FYI..the local Dominos pizza doesn’t even deliver as it is such a small town .Great. I can finally take a vacation. However, you are incorrect, as I am actually doing my job and that of several others I might add, to conserve cash flow for the shareholders (who prefer to b me ) and I am doing it quite well. What I and the team have done at bell is extraordinary and bell is cranking on all cylinders even though the job comes with zero appreciation and no pay.
CELZ News 5/6/2019..CaverStem Stem Cell Treatment Of Erectile Dysfunction Receives Additional International Exposure
7:45 AM ET 5/6/19 | Dow Jones
PHOENIX and ROME, May 6, 2019 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today coverage of its patented CaverStem(R) technology for treatment of erectile dysfunction using the patient's own non-manipulated and non-expanded stem cells in multiple Italian publications.
"We are pleased that our CaverStem(R) procedure has gained such international exposure in the few months since Prof. Gabriele Antonini MD, PhD has begun treating patients in Italy," said Timothy Warbington, CEO of Creative Medical Technology Holdings, Inc.
The publications include: Adnkronos, Momento Italia, DottNet and Secolo de Italia. Excerpts of the interview with Dr. Antonini, translated from Italian to English are as follows:
"A natural, non-invasive and permanent treatment to regenerate blood vessels and smooth muscles within the sexual organ of patients with erectile dysfunction. A real 'bombshell' to revive their sex life. It's called CaverStem(R) and is a patented medical protocol in the United States, also available in Italy," emphasizes the Adnkronos Salute Gabriele Antonini, urologist-andrologist from Rome.
"In the field of biomedical research, regenerative medicine has successfully established itself in the last decade through the development of new strategies and alternative treatments to conventional therapies, using growth factors and other intercellular signals capable of stimulating the natural process of healing of the human body," remarks Dr. Antonini.
So, how does 'bombing' with stem cells work? "We use hematopoietic, mesenchymal and endothelial progenitor cells present in the patient's bone marrow," explains Dr. Antonini. "The administration of stem cells directly into the penis can reverse the pathophysiological changes that lead to erectile dysfunction, in addition to treating the symptoms effectively. In about 15 minutes, the urologist specialist proceeds with local anesthesia to extract a small amount of autologous material from the iliac crest from the patient and obtains a concentrated cellular product that is injected into the corpus cavernosum of the patient's penis."
"The CaverStem(R) procedure, scientifically already validated in the USA, allows for a safe, fast and free of collateral effects in an outpatient procedure," highlights Dr. Antonini. "Only three months after implantation, an increase in duration and frequency of erection was detected, in addition to maintaining it until orgasm was reached."
"The side effects are practically absent, and no post-procedure complication has occurred," explains Dr. Antonini. "CaverStem(R) shows a truly rosy future for the non-invasive and non-surgical treatment of erectile dysfunction."
"The patient progress in Italy is indicative of reports by physicians in the United States. We are continuing to bring on board other domestic and international physicians and are highly optimistic with the future of CaverStem(R) in the United States and Internationally," said Timothy Warbington.
CaverStem(R) is a registered trademark in the United States and a pending trademark in The European Union.
For more information on our erectile dysfunction technology please go to www.Caverstem.com.
About Creative Medical Technology Holdings
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company specializing in stem cell technology in the fields of urology, neurology and orthopedics and trades on the OTCQB under the ticker symbol CELZ. For further information about the company go to www.creativemedicaltechnology.com.
Forward Looking Statements
OTC Markets has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc. Forward-looking statements address future events and conditions and, therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at www.sec.gov.
Publications cited:
https://www.adnkronos.com/salute/medicina/2019/05/04/dagli-usa-italia-staminali-bombita-contro-disfunzione-erettile_JgeCu0fOCt6ChtwQ4XDEGN.html?refresh_ce
https://www.dottnet.it/articolo/27651/contro-la-disfunzione-erettile-trattamento-con-staminali/
https://www.secoloditalia.it/2019/05/sanita-ce-il-si-del-ministero-in-italia-la-bombita-per-rilanciare-la-vita-sessuale/
https://www.momentoitalia.it/sesso-dagli-usa-in-italia-le-staminali-bombita-contro-disfunzione-erettile/61549/
View original content:http://www.prnewswire.com/news-releases/caverstem-stem-cell-treatment-of-erectile-dysfunction-receives-additional-international-exposure-300844049.html
SOURCE Creative Medical Technology Holdings, Inc.
/CONTACT: Creative Medical Technology Holdings, Inc., ceo@creativemedicalhealth.com, Tel: 480-789-9939
/Web site: http://creativemedicaltechnology.com
> Dow Jones Newswires
May 06, 2019 07:45 ET (11:45 GMT)
BANT Anything happening around here?
CELZ Going green soon :)
CELZ News 4/30/2019 Creative Medical Technology Holdings, Inc. April 2019 Shareholder Update
9:15 AM ET 4/30/19 | Dow Jones
PHOENIX, April 30, 2019 /PRNewswire/ -- (OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its activities:
As we are releasing updates on a regular basis, we will only cover new activities. The absence of reporting on a specific area of our business should not be construed as a lack of concentration in that area but due to the short window of time between shareholder updates. We appreciate our shareholders' desire for "real time" information but some aspects of our business take time.
CaverStem(TM) domestic activities: We are continuing marketing to physicians across the United States. Since our last shareholder update an additional five physicians have expressed interest in joining CaverStem(TM). We are currently vetting those physicians and will submit contracts for their review and signature. Once contracts are in place, we will schedule training and begin marketing for patient awareness.
These physicians came to us through our physician marketing program. We are continuing to use this marketing tool with mailers and emails with follow up telephone communication with physicians across the country.
As previously disclosed, we have and will continue to use social media to build patient awareness with the use of Google Ad Words and banner advertising. We believe social media is a great resource as 80% of patients find us, using their phones and tablets. In order to continue to grow patient awareness print advertising is now being used and we are continuing to develop our television commercial which will be edited to direct patients to each physician in their area.
Dr. Narayan and his staff at North Florida Urology were trained on April 24(th) with five patients successfully treated. Training for Dr. Liu in San Francisco is scheduled on May 2(nd) and Dr. Sanderson in Honolulu will be trained in May. Other physicians are scheduled the first of June.
Patient testimonials discussing the procedure and the positive results are being filmed and will be posted on our caverstem.com website and our social media pages.
CaverStem(TM) International activities: We are continuing to treat patients in Italy and the first patients treated within the past 2 months have expressed positive results. This will be covered in a separate press release by Dr. Antonini and the company.
Additionally, our electronic patient registry is complete and is being forwarded to physicians. This registry is intended to include data from our clinical trial, data from treating physicians using centrifuge technology with a 30cc to 60cc bone marrow aspiration and our second generation, needle only, mini bone marrow aspiration technology drawing a maximum of 20cc of bone marrow. Recent publications have disclosed that with the second generation needle technology a larger amount of pure cell product is harvested because of a reduction in dilution of blood, thus requiring a reduced bone marrow aspiration. The registry will enable the company to gather and maintain ongoing HIPAA compliant information on patient demographics, history and treatment progress. Patient names and addresses will not be included on the registry or disclosed to the company.
We have received positive feedback from treating physicians in the United States and Europe of a 70% to 100% efficacy in their patients. This percentage may fluctuate depending on the age and health of the patients and cause and severity of their erectile dysfunction.
FemCelz(TM): as previously announced, we are progressing with the development of the FemCelz(TM) procedure for the treatment of female sexual dysfunction. The first patients are scheduled for May 2(nd) in San Francisco. Additional patients are being scheduled in other cities.
We continue to move forward on all aspects of our business. The dedication of our team towards building the fundamentals of the company and shareholder value remain as strong as ever and the addition of medical industry veterans allows us to grow the company on a domestic and international level at a faster pace than at any time since inception of the company.
We would also like to thank our shareholders for their support, including the many shareholders from the medical field who have expressed positive feedback on our progress.
We are currently finalizing our Q1 financials and expect to file by the May 15, 2019 deadline.
About Creative Medical Technology Holdings
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company currently trading on the OTCQB under the ticker symbol CELZ. For further information about the company go to www.creativemedicaltechnology.com. For more information on our Caverstem(TM) procedure please go to www.caverstem.com.
Forward-Looking Statements
OTC Markets has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc. Forward-looking statements address future events and conditions and, therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at www.sec.gov.
View original content:http://www.prnewswire.com/news-releases/creative-medical-technology-holdings-inc-april-2019-shareholder-update-300840743.html
SOURCE Creative Medical Technology Holdings, Inc.
/CONTACT: Timothy Warbington, Chief Executive Officer, Tel: (480) 789-9939
/Web site: http://www.creativemedicaltechnology.com/
> Dow Jones Newswires
April 30, 2019 09:15 ET (13:15 GMT)
ALKM Time for them to add a 3rd shift on the Quick Fill Line.
ALKM Crystal ball cracked. No one can tell the future. To say otherwise is a broken record. :)
GRDO Light is always on....... LMAO!
04/25/2019 Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information 12/31/2018 A
04/17/2019 Annual Report - Amended Annual Report for Period Ending December 31, 2018
https://www.otcmarkets.com/stock/GRDO/disclosure
GRDO SECURITY DETAILS
Share Structure
Market Cap
3,874,661
04/25/2019
Authorized Shares
2,430,500,000
04/12/2019
Outstanding Shares
2,152,589,568
04/12/2019
Restricted
10,950,072
04/12/2019
Unrestricted
2,141,639,496
04/12/2019
Transfer Agent Verified
https://www.otcmarkets.com/stock/GRDO/security
Looks like a flux capacitor. Go to 2021 and see what the SP is then. :)
04/25/2019 Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information
https://www.otcmarkets.com/stock/GRDO/disclosure
ALKM anyone can buy bottling equipment, they need the patented process!
ALKM..Brian Shibley has confirmed plans to acquire the company’s current bottler. The acquisition will result in the expansion of the bottler’s production capacity to address growing demand.
“As we continue to innovate new beverages, a key bottling partner or in-house capacity it’s essential. Be it an acquisition or a new build out, the plan will be finalized this month, and we will proceed quickly to expand production capacity one way or another,” explained Mr. Shibley.
GRDO..So far just U and all that read your post. Awsome. :)
ALKM...Simple Hemp Oil
11 mins ·
Try Simple CBD’s Coconut Lemon Aid! With the potent combination of Alkame’s specially formulated oxygenated water, pure natural coconut water, and 25mg of nano emulsified organic hemp cannabidiol. Each of these unique ingredients brings its own set of health benefits, offering increased absorption and maximum results. Wellness has never been so easy or tasted so good!
Simple CBD
Simple Pure, Naturally Effective
https://www.simplecbd.org
Just FYI...U.S. exchanges are closed on April 19 for Good Friday: Learn more about trade settlement, account funding, and our hours of operation.
A PR on Good Friday? Could be the start of a resurrection.